What is the story about?
What's Happening?
LabConnect, a provider of central laboratory services, has partnered with OmniScience to deliver an AI Agentic solution for real-time clinical trial lab insights. This collaboration aims to unify fragmented lab datasets, automate oversight, and surface risk signals, thereby accelerating trial timelines and improving outcomes. The AI-native platform, Vivo, functions as a control tower to provide clarity and actionable intelligence to clinical teams.
Why It's Important?
The integration of AI into clinical trial processes can significantly enhance decision-making and reduce risks associated with delayed or siloed data. By providing real-time insights, this collaboration has the potential to streamline lab workflows, improve trial efficiency, and ultimately lead to faster and more reliable clinical outcomes. This advancement could benefit sponsors, researchers, and patients by expediting the development of new treatments.
AI Generated Content
Do you find this article useful?
